Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Ischemic Stroke. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Russia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN® Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome
Overview
Post intensive care syndrome (PIC syndrome) is an important problem in modern intensive care strategy. Understanding the mechanisms of PIC syndrome helps prevent it in patients with respiratory, neuromuscular transmission, and cognitive impairments that require prolonged support of vital functions. Significant role in the formation and severity of PIC syndrome is played by the severity of the systemic inflammatory response, which is an individual reaction of the body, and this determines the degree of neurological and psychological deficits. Chronic diseases such as diabetes mellitus, especially in the context of metabolic syndrome, worsen the course of PIC syndrome and delays recovery. Early initiation of rehabilitation measures in the intensive care unit and subsequent expansion of the individual rehabilitation program contributes to the rapid and successful recovery of not only vital functions, but also cognitive, motor and emotional disorders. This shortens the hospital stay of patient and improves their quality of life after discharge.
Primary outcome measures
- Dynamics of rehabilitation routing status score [Time frame: day 12, day 30, day 60, day 90]
- Dynamics of Barthel status score [Time frame: day 12, day 30, day 60, day 90]
- Dynamics of EQ5 status score [Time frame: day 12, day 30, day 60, day 90]
Secondary outcome measures (2)
- Dynamics of somatic status [Time frame: day 12, day 30, day 60, day 90]
- Dynamics of rehabilitation status [Time frame: day 12, day 30, day 60, day 90]
Eligibility criteria
Inclusion criteria
- Men and women over 18 years of age and older;
- Stay in the ITU and (or) intensive care unit for at least 3 days;
- Diagnosed "post intensive care" syndrome (PIC syndrome) with moderate-to-severe severity >3<6 points
- Diagnosed modalities "critical illness polyneuropathy, respiratory neuropathy, dysphagia" of the domain "Neuromuscular complications" of PIC syndrome at 2-3 stages of the rehabilitation route at any value of PICS severity index
- Diagnosed modalities "decreased gravitational gradient, decreased exercise tolerance" in the domain "Vegetative-metabolic complications" at 2-3 stages of the rehabilitation route at any value of PICS severity index
Exclusion criteria
- Premorbid level of vital activity when assessed on the rehabilitation routing scale 4-5 points;
- Hematocrit ≤30%;
- Hemoglobin level ≤80 g/L;
- Acute cardiac failure;
- Acute respiratory failure;
- Acute renal failure;
- Acute liver cell failure;
- Use of drugs from "metabolic agents" pharmacotherapeutic group at the time of inclusion in the study
- Life expectancy of 6 months or less or presence of incurable diseases in decompensation stage
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
Russia · 1 center
- Brain Institute Clinic — Yekaterinburg
Identifiers
NCT: NCT06735898 · PR-C_2